Moberg Pharma AB (publ) (STO: MOB)

Moberg Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	154.96	174.8	171.93	106.01	41.47	51.25
Short-Term Investments	285	-	66.74	20	-	10
Cash & Short-Term Investments	439.96	174.8	238.67	126.01	41.47	61.25
Cash Growth	92.31%	-26.76%	89.40%	203.88%	-32.30%	175.12%
Accounts Receivable	12	29.48	18.37	6.69	8.03	2.93
Other Receivables	50.21	362.25	90.48	25.34	7.88	3.37
Receivables	62.22	391.73	108.85	32.03	15.91	6.3
Inventory	217.58	191.31	370.71	25.79	8.4	0.43
Prepaid Expenses	4.08	14.58	4.02	6.81	5.4	2.28
Total Current Assets	723.83	772.42	722.25	190.64	71.18	70.26
Property, Plant & Equipment	953.73	964.4	845.32	1,022	608.29	364.51
Long-Term Investments	61.6	61.6	32.69	315.9	311.05	148.63
Other Long-Term Assets	-	6.04	6.04	39.62	39.62	143.35
Total Assets	1,739	1,804	1,606	1,568	1,030	726.75
Accounts Payable	13.13	23.72	30.53	7.95	10.81	11.12
Accrued Expenses	74.61	11.16	4.85	3.53	3.85	6.18
Short-Term Debt	-	-	-	-	3.94	-
Current Portion of Long-Term Debt	21.61	25.38	17.34	5.22	20.52	22.22
Current Income Taxes Payable	4.67	0.75	-	5.46	4.03	0.8
Current Unearned Revenue	-	88.39	24.36	25.1	21.81	25.92
Other Current Liabilities	2.95	17.44	5.23	0.73	0.49	84.85
Total Current Liabilities	116.96	166.83	82.31	47.98	65.45	151.08
Long-Term Debt	317.55	331.6	86.69	183.6	201.09	200.91
Long-Term Deferred Tax Liabilities	1.18	1.18	4.2	20.37	4.36	4.06
Total Liabilities	435.69	499.62	173.2	251.95	270.9	356.04
Common Stock	659.67	659.67	659.67	659.67	435.48	242.89
Additional Paid-In Capital	553.79	579.79	553.79	553.79	253.73	60.6
Retained Earnings	90.01	-	-	102.95	70.02	67.22
Comprensive Income & Other	-	65.37	219.64	-	-	-
Shareholders' Equity	1,303	1,305	1,433	1,316	759.23	370.7
Total Liabilities & Equity	1,739	1,804	1,606	1,568	1,030	726.75
Total Debt	339.15	356.98	104.03	188.82	225.55	223.13
Net Cash (Debt)	100.81	-182.18	134.64	-62.8	-184.08	-161.87
Net Cash Per Share	1.27	-2.30	1.70	-0.84	-4.14	-5.55
Filing Date Shares Outstanding	79.16	79.16	79.16	79.16	52.26	29.15
Total Common Shares Outstanding	79.16	79.16	79.16	79.16	52.26	29.15
Working Capital	606.87	605.58	639.94	142.66	5.73	-80.82
Book Value Per Share	16.47	16.48	18.10	16.63	14.53	12.72
Tangible Book Value	1,303	1,305	1,433	1,316	759.23	370.7
Tangible Book Value Per Share	16.47	16.48	18.10	16.63	14.53	12.72
Land	-	676.16	557.76	294.54	155.33	144.08
Buildings	-	302.53	289.8	475.29	353.99	131.1
Machinery	-	65.84	58.63	127.35	52.85	52.79
Construction In Progress	-	4.55	7.79	176.91	85.6	69.23

Source: S&P Capital IQ. Standard template. Financial Sources.